software package graphpad prism version 9 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
software package graphpad prism version 9
Software Package Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+package+graphpad+prism+version+9/graphpad+prism+software/pmc12030389-155-2-3
Average 90 stars, based on 1 article reviews
Software Package Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+package+graphpad+prism+version+9/graphpad+prism+software/pmc12030389-155-2-3
Average 90 stars, based on 1 article reviews
software package graphpad prism version 9 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Epidemiologic and molecular characterization of β-lactamase-producing multidrug-resistant uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients. Article Snippet: Uropathogenic Escherichia coli (UPECs) are the predominant cause of asymptomatic bacteriuria (ABU) and symptomatic UTI.. In this study, multidrug-resistant (MDR) ABU-UPECs from hospitalized patients of Kolkata, India, were characterized with respect to their ESBL phenotype, acquisition of β-lactamase genes, mobile genetic elements (MGEs), phylotype property, ERIC-PCR profile, sequence types (STs), clonal complexes (CCs) and evolutionary and quantitative relationships and compared to the symptomatic ones to understand their epidemiology and evolutionary origin.. Statistically significant incidence of ESBL producers, β-lactamase genes, MGEs and novel phylotype property (NPP) among ABU-UPECs similar to the symptomatic ones indicated the probable incidence of chromosomal plasticity on resistance gene acquisition through MGEs due to indiscriminate drug usage. Article Title: Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends. Article Snippet: Urinary tract infection (UTI), a prevalent disease in India, also ranks among the most common infections in developing countries.. The rapid emergence of antibiotic-resistant uropathogenic Escherichia coli (UPECs), the leading etiologic agent of UTI, in the last few years, led to an upsurge in the health care cost.. This caused a considerable economic burden, especially in low-middle income country, India. |